Screening Dicer-substrate siRNA duplexes enable fast, cost-effective siRNA

CORALVILLE, Iowa – Integrated DNA Technologies (IDT), a world leader in oligonucleotide production, has announced the launch of its Screening Dicer-substrate siRNA (DsiRNA) duplex product. Ideal for small scale in vitro applications, Screening DsiRNAs provide researchers with a cost effective and quick solution for their RNAi experiments. All duplexes ship within 4 working days and are QC analyzed by ESI mass spectrometry to verify compound identity.

Produced on IDT’s proprietary high-throughput synthesis platform, the manufacturing process includes Affinity purification and has been designed to provide a high quality product at a low cost. Available in either tubes or plates, IDT offers a 2 or 10 nanomole scale yields. DsiRNA methods were developed in a collaborative project between IDT and Prof. John Rossi at the Beckman Research Institute of the City of Hope National Medical Center

Since 1987, IDT has been a major force in advancing biotechnology research, both as a leading supplier of custom oligonucleotides and a developer of innovative new biotechnologies. Known for producing dependable products of the highest quality, the company is now extending these attributes to the field of screening RNAi. For further information, visit www.idtdna.com.